Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Study combines structural and functional tests to monitor progression of COPD

Dec. 2, 2010

Phase II data presented on imatinib in diffuse cutaneous systemic sclerosis

Dec. 2, 2010

Elara Pharma's new antitumor agent EL-102 inhibits HIF-1-alpha and cellular proliferation

Dec. 2, 2010

PI3K-delta inhibitor XL-499 shows promising preclinical activity

Dec. 2, 2010

Atrasentan reduces albuminuria in patients with diabetes-associated nephropathy

Dec. 1, 2010

Pfizer's AadAT inhibitor PF-4859989 shows activity in vivo

Dec. 1, 2010

Phase I data presented on MEDI-573 and MEDI-575 in advanced solid tumors

Dec. 1, 2010

Multikinase inhibitor AI-1008 shows promise to treat chronic myeloid leukemia in preclinical testing

Dec. 1, 2010

Preclinical activity of LY-S6KAKT1 justifies entry into phase I trial as cancer therapy

Dec. 1, 2010

CXR-1002 shows promising safety and antitumor activity in first-in-human trial in advanced cancer

Nov. 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...